Drug intelligence / Profile preview

isodeoxyelephantopin

Development stage
Preclinical
Modality
Small Molecules
Administration
In Vitro (preclinical Research; Clinical Routes Not Established)
01

Overview

Isodeoxyelephantopin is a natural sesquiterpene lactone isolated primarily from Elephantopus scaber and Elephantopus carolinianus, plants used in traditional Asian medicine. It displays anti-cancer and anti-inflammatory effects by targeting multiple intracellular signaling pathways. Its anti-tumor activity involves the induction of apoptosis, cell cycle arrest (notably G2/M), and autophagy in cancer cells through modulation of pathways such as NF-κB, AP-1, and MAPK, and generation of reactive oxygen species (ROS). Isodeoxyelephantopin also inhibits inflammatory mediators (including inducible nitric oxide synthase, interleukins, and chemokines) in macrophages by suppressing nuclear factor-κB and activator protein-1 activity. The compound is under early preclinical investigation for its use against breast, lung, leukemia, and other cancer types, as well as inflammatory conditions[1][3][5][6][7][9][11].

Other names
sodeoxyelephantopin2-Propenoic acid, 2-methyl-, (3aR,4S,9S,11E,12aR)-2,3,3a,4,5,9,10,12a-octahydro-11-methyl-3-methylene-2,7-dioxo-7H-9,6-methenofuro[2,3-f]oxacycloundecin-4-yl ester
02

Targets

TXNRD1 (Thioredoxin reductase 1)JNK (Mitogen-activated protein kinase kinase kinase family)RELA (Nuclear Factor Kappa B Subunit p65)MAPK3 (Mitogen-activated protein kinase 1)FOS (Activator Protein 1)

Beyond the preview

Go deeper on isodeoxyelephantopin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isodeoxyelephantopin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call